Aqeel A. Al-Sadawi (1), Ali Reyadh Medhat (2), Ruaa Kareem Surhan (3), Ahmed Al Obaidi (4)
Extracellular vesicle-associated microRNAs (EV-miRNAs) have gained recognition as key regulators of immune processes during bacterial infections. This meta-analysis aims to comprehensively assess the expression dynamics, diagnostic value, and immunological implications of EV-associated miRNAs during bacterial infections. A systematic review of studies indexed in PubMed, Scopus, and Web of Science was performed through May 2025, following PRISMA 2020 criteria. A total of 42 studies involving 2,348 samples from human and animal sources were included. Data extracted covered miRNA profiles, detection techniques (RT-qPCR, RNA-seq, microarray), infection types, and sample origins (plasma, serum, BAL, CSF). A random-effects meta-analysis was conducted, supplemented by subgroup and sensitivity analyses. Publication bias was evaluated using funnel plots and Egger’s test. Five EV-miRNAs—miR-155, miR-146a, miR-21, miR-223, and miR-29a—were found to be significantly upregulated in ≥10 studies. The most prominent pooled effect size was observed for miR-21 (SMD: 1.52; 95% CI: 1.10–1.94; p < 0.0001). Subgroup analyses revealed stronger expression in Gram-negative infections and in plasma-based samples. RNA-seq outperformed RT-qPCR in sensitivity. No significant publication bias was detected. Sensitivity tests confirmed the robustness of the findings. Functional enrichment pointed to roles in NF-κB/TLR signaling, macrophage polarization, and cytokine modulation. EV-associated miRNAs show consistent and significant dysregulation during bacterial infections, highlighting their potential as biomarkers and immunoregulatory agents. These findings warrant further validation in prospective and functional studies.
Highlights:
These EV-miRNAs are strongly linked to NF-κB/TLR signaling, macrophage polarization, and cytokine modulation, highlighting their biomarker and therapeutic potential.
1. Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2021;184(6):1226–42.
2. van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2022;23(8):469–84.
3. He X, Zhang J, Chen C, Wang X. The role of miRNAs in immune response and inflammation in bacterial infections. J Transl Med. 2022;20(1):110.
4. Haneklaus M, O’Neill LA. miR-155 at the heart of inflammation. Eur J Immunol. 2021;51(6):1412–21.
5. Liu H, Zhang M, Qin L, Xu D, Wang Y. Differential expression of exosomal miRNAs in Pseudomonas aeruginosa-induced otitis media. Int J Pediatr Otorhinolaryngol. 2021;143:110623.
6. Yang Y, Liu H, Zhang H, Ye Q. Extracellular vesicle-derived microRNAs as biomarkers in Mycobacterium tuberculosis infection: a meta-analysis. Biomed Res Int. 2023;2023:6689057.
7. Kandasamy K, Pandian SK. Altered expression of urinary EV-miRNAs in E. coli-mediated urinary tract infections. Front Cell Infect Microbiol. 2020;10:586202.
8. Wang Y, Xu H, Ma H, et al. Extracellular vesicle-derived miRNAs as biomarkers in infectious diseases. Front Cell Dev Biol. 2021;9:660101.
9. Zhou H, Chen Y, Li Y, et al. The role of circulating exosomal microRNAs in bacterial infections. Front Cell Infect Microbiol. 2022;12:883695.
10. Zhu D, Gu L, Li Z, et al. Exosomal miR-155 promotes macrophage inflammatory phenotype. Front Immunol. 2021;12:650191.
11. Li H, Jiang Y, Jiang Y, et al. Regulatory role of miR-146a in bacterial infection and sepsis: a systematic review. Front Genet. 2022;13:864327.
12. Sun Y, Zhao Y, Yang Y, et al. miR-21 modulates immune response via targeting PDCD4 in bacterial sepsis. Mediators Inflamm. 2020;2020:4512345.
13. Zhang X, Li Y, Wang X, et al. The role of miR-223 and miR-29a in modulating immune responses during infection. Cell Biosci. 2021;11(1):25.
14. Wang X, Sun X, Tan Y, et al. miR-223 regulates innate immunity and systemic inflammation during bacterial infection. J Transl Med. 2020;18(1):362.
15. Shah R, Patel T, Freedman JE. Circulating extracellular vesicles as biomarkers in sepsis and infection. Clin Transl Med. 2021;11(9):e495.
16. Yang D, Zhang W, Zhang H, et al. Clinical value of circulating microRNAs packed in extracellular vesicles for diagnosis of sepsis. Biomed Pharmacother. 2021;139:111610.
17. Han X, Sun Z, Liu L, et al. Therapeutic targeting of exosomal miRNAs in infectious diseases. Theranostics. 2020;10(20):9181–97.
18. Liu C, Su C, Chen Q, et al. A systematic review of EV-miRNA detection platforms and biases in infection diagnostics. Front Bioeng Biotechnol. 2023;11:1020913.
19. Martinez-Gutierrez M, Díaz-Salazar C, Cano-Cano FJ, et al. Differential expression of EV-miRNAs in viral vs bacterial pneumonia. J Transl Med. 2022;20(1):134.
20. Choi H, Lee DS. miRNA expression profiles during innate immune responses to bacterial and viral infections in humans. Cells. 2020;9(8):1853.
21. Zhu Y, Yu J, Liu Y, et al. Longitudinal profiling of extracellular vesicle cargoes during bacterial pneumonia. Sci Rep. 2021;11:22048.
22. Tsering T, Zhang M, Xiong M, et al. Multi-omic profiling of extracellular vesicles in infection: opportunities and challenges. Trends Biotechnol. 2022;40(11):1248–62.